Journey Medical Corporation
DERM
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycyclā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
4 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$6.39
Price+0.31%
$0.02
1Y
Price
Market Cap
$175.864m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-1.2%
EBITDA Margin-14.0%
Net Profit Margin+18.2%
Free Cash Flow Margin-1.2%
EBITDA Margin-14.0%
Net Profit Margin+18.2%
Free Cash Flow MarginRevenue
$64.680m
+4.6%
1y CAGR-4.8%
3y CAGR-1.7%
5y CAGREarnings
-$9.588m
+16.1%
1y CAGR-80.9%
3y CAGR-38.9%
5y CAGREPS
-$0.38
+19.2%
1y CAGR-63.0%
3y CAGR-25.4%
5y CAGRBook Value
$30.831m
$91.534m
Assets$60.703m
Liabilities$25.467m
DebtDebt to Assets
27.8%
-17.7x
Debt to EBITDAFree Cash Flow
-$6.700m
+46.2%
1y CAGR-1297.7%
3y CAGR-948.1%
5y CAGRNo items found.
Press Releases
Statements and updates from the company